MICAFUNGIN - THE NEWEST ECHINOCANDIN

被引：11
作者：
Temesgen, Zelalem [1 ]
Barreto, Jason N. [1 ]
Vento, Sandro [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Annunziata Hosp, Cosenza, Italy
来源：
DRUGS OF TODAY | 2009年 / 45卷 / 06期
关键词：
LIPOSOMAL AMPHOTERICIN-B; LIPOPEPTIDE ANTIFUNGAL AGENT; IN-VITRO ACTIVITY; NERVOUS-SYSTEM ASPERGILLOSIS; INVASIVE FUNGAL-INFECTIONS; STEM-CELL TRANSPLANTATION; DEEP-SEATED MYCOSIS; DOUBLE-BLIND TRIAL; DISSEMINATED CANDIDIASIS; ESOPHAGEAL CANDIDIASIS;
D O I：
10.1358/dot.2009.45.6.1378277
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Micafungin is one of three currently FDA-approved echinocandins. It has potent in vitro activity against Candida species including non-albicans Candida and azole-resistant Candida species and has also demonstrated clinical efficacy against deep-seated Candida infections. Additional in vitro data and preliminary clinical efficacy studies suggest that it also has utility for the treatment of infections caused by Aspergillus species. However, its approved indications remain for the treatment of both invasive and esophageal candidiasis and for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. Micafungin is generally well tolerated with few significant adverse effects.
引用
收藏
页码：469 / 478
页数：10
相关论文
共 51 条
[21]   Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits [J].
Hiraoka, Takahiro ;
Kaji, Yuichi ;
Wakabayashi, Taketoshi ;
Nanbu, Patricia N. ;
Okamoto, Fumiki ;
Oshika, Tetsuro .
CORNEA, 2007, 26 (03) :336-342
[22]   Pharmacokinetics of antifungal agent micafungin in critically ill patients receiving continuous hemodialysis filtration [J].
Hirata, Kiyotaka ;
Aoyama, Takahiko ;
Matsumoto, Yoshiaki ;
Ogawa, Futosi ;
Yamazaki, Hiroshi ;
Kikuti, Arimichi ;
Yamamoto, Yasuhiro .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (05) :897-901
[23]   Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis [J].
Hope, William W. ;
Drusano, George L. ;
Moore, Caroline B. ;
Sharp, Andrew ;
Louie, Arnold ;
Walsh, Thomas J. ;
Denning, David W. ;
Warn, Peter A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) :285-295
[24]   Opportunistic mycelial fungal infections in organ transplant recipients:: Emerging importance of non-Aspergillus mycelial fungi [J].
Husain, S ;
Alexander, BD ;
Munoz, P ;
Avery, RK ;
Houston, S ;
Pruett, T ;
Jacobs, R ;
Dominguez, EA ;
Tollemar, JG ;
Baumgarten, K ;
Yu, CM ;
Wagener, MM ;
Linden, P ;
Kusne, S ;
Singh, N .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :221-229
[25]   Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis [J].
Ikeda, F ;
Wakai, Y ;
Matsumoto, S ;
Maki, K ;
Watabe, E ;
Tawara, S ;
Goto, T ;
Watanabe, Y ;
Matsumoto, F ;
Kuwahara, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :614-618
[26]   Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults [J].
Keirns, J. ;
Sawamoto, T. ;
Holum, M. ;
Buell, D. ;
Wisemandle, W. ;
Alak, A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :787-790
[27]   A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan [J].
Kohno, S ;
Masaoka, T ;
Yamaguchi, H ;
Mori, T ;
Urabe, A ;
Ito, A ;
Niki, Y ;
Ikemoto, H .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (05) :372-379
[28]   Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial [J].
Kuse, Ernst-Ruediger ;
Chetchotisakd, Ploenchan ;
da Cunha, Clovis Arns ;
Ruhnke, Markus ;
Barrios, Carlos ;
Raghunadharao, Digumarti ;
Sekhon, Jagdev Singh ;
Freire, Antonio ;
Ramasubramanian, Venkatasubramanian ;
Demeyer, Ignace ;
Nucci, Marcio ;
Leelarasamee, Amorn ;
Jacobs, Frederique ;
Decruyenaere, Johan ;
Pittet, Didier ;
Ullmann, Andrew J. ;
Ostrosky-Zeichner, Luis ;
Lortholary, Olivier ;
Koblinger, Sonja ;
Diekmann-Berndt, Heike ;
Cornely, Oliver A. .
LANCET, 2007, 369 (9572) :1519-1527
[29]   In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients [J].
Laverdiere, M ;
Hoban, D ;
Restieri, C ;
Habel, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) :119-123
[30]   Combined antifungal therapy in a murine infection by Candida glabrata [J].
Marine, Marcal ;
Serena, Carolina ;
Pastor, F. Javier ;
Guarro, Josep .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) :1295-1298
123456